Ethiopia’s malaria response, already disrupted by the impacts of COVID-19, is grappling with the multi-faceted challenges of an ongoing uptick in new cases, complicated by vector resistance to insecticides.
Driven by the continued fallout of pandemic-related programme disruptions, armed conflict, and displacement, Ethiopia recorded a 32,5% increase in confirmed malaria cases between 2021 and 2022, from 1,1m to 1,5m. To date in 2023, reported malaria cases have increased by 150% and 120%, respectively, compared to the same periods in 2021 and 2022.